77 related articles for article (PubMed ID: 19915764)
41. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
Lu X; Toki T; Konishi I; Nikaido T; Fujii S
Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
[TBL] [Abstract][Full Text] [Related]
42. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044
[TBL] [Abstract][Full Text] [Related]
43. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
44. Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma.
Shapira M; Ben-Izhak O; Bishara B; Futerman B; Minkov I; Krausz MM; Pagano M; Hershko DD
Cancer; 2004 Apr; 100(8):1615-21. PubMed ID: 15073847
[TBL] [Abstract][Full Text] [Related]
45. [Morphological prognostic elements in gallbladder cancer].
Roa I; de Aretxabala X; Araya JC; Villaseca M; Roa J; Gilda IT; Burgos L; Muñoz S
Rev Med Chil; 2002 Apr; 130(4):387-95. PubMed ID: 12090103
[TBL] [Abstract][Full Text] [Related]
46. An immunohistochemical study of p21 and p53 expression in primary node-positive breast carcinoma.
O'Hanlon DM; Kiely M; MacConmara M; Al-Azzawi R; Connolly Y; Jeffers M; Keane FB
Eur J Surg Oncol; 2002 Mar; 28(2):103-7. PubMed ID: 11884043
[TBL] [Abstract][Full Text] [Related]
47. Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers.
Migaldi M; Sgambato A; Garagnani L; Ardito R; Ferrari P; De Gaetani C; Cittadini A; Trentini GP
Clin Cancer Res; 2000 Aug; 6(8):3131-8. PubMed ID: 10955794
[TBL] [Abstract][Full Text] [Related]
48. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
[TBL] [Abstract][Full Text] [Related]
49. Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry.
Takagawa M; Muguruma N; Oguri K; Imoto Y; Okamoto K; Ii K; Ito S
Dig Dis Sci; 2005 Aug; 50(8):1410-3. PubMed ID: 16114133
[TBL] [Abstract][Full Text] [Related]
50. Gallbladder cancer in Chile: Pathologic characteristics of survival and prognostic factors: analysis of 1,366 cases.
Roa I; Ibacache G; Muñoz S; de Aretxabala X
Am J Clin Pathol; 2014 May; 141(5):675-82. PubMed ID: 24713738
[TBL] [Abstract][Full Text] [Related]
51. Immunoreactivity and prognostic value of tumor-associated glycoprotein 72 in primary gallbladder carcinoma.
Ouyang M; Wu W; Zou Y; Zhou J; Wang Z; Wan X
Surg Oncol; 2010 Jun; 19(2):82-7. PubMed ID: 19447030
[TBL] [Abstract][Full Text] [Related]
52. Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas.
Chang HJ; Yoo BC; Kim SW; Lee BL; Kim WH
Pathol Oncol Res; 2007; 13(4):326-35. PubMed ID: 18158568
[TBL] [Abstract][Full Text] [Related]
53. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
Miyahara N; Shoda J; Kawamoto T; Furukawa M; Ueda T; Todoroki T; Tanaka N; Matsuo K; Yamada Y; Kohno K; Irimura T
Clin Cancer Res; 2004 Mar; 10(6):2090-9. PubMed ID: 15041730
[TBL] [Abstract][Full Text] [Related]
54. Establishment and characterization of 38 novel patient-derived primary cancer cell lines using multi-region sampling revealing intra-tumor heterogeneity of gallbladder carcinoma.
Feng F; Cheng Q; Li B; Liu C; Wang H; Li B; Xu X; Yu Y; Chen Z; Wu X; Dong H; Chu K; Xie Z; Gao Q; Xiong L; Li F; Yi B; Zhang D; Jiang X
Hum Cell; 2021 May; 34(3):918-931. PubMed ID: 33813726
[TBL] [Abstract][Full Text] [Related]
55. Role of nicotine in gallbladder carcinoma: a preliminary report.
Basu S; Priya R; Singh TB; Srivastava P; Mishra PK; Shukla VK
J Dig Dis; 2012 Oct; 13(10):536-40. PubMed ID: 22988927
[TBL] [Abstract][Full Text] [Related]
56. Deregulation of MYC and TP53 through genetic and epigenetic alterations in gallbladder carcinomas.
Ishak G; Leal MF; Dos Santos NP; Demachki S; Nunes CA; do Nascimento Borges B; Calcagno DQ; Smith MC; Assumpção PP; Burbano RR
Clin Exp Med; 2015 Aug; 15(3):421-6. PubMed ID: 25200035
[TBL] [Abstract][Full Text] [Related]
57. Cyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomas.
Legan M
Bosn J Basic Med Sci; 2010 Aug; 10(3):192-6. PubMed ID: 20846124
[TBL] [Abstract][Full Text] [Related]
58. GBCdb: RNA expression landscapes and ncRNA-mRNA interactions in gallbladder carcinoma.
Guo L; Xiang Y; Dou Y; Yin Z; Xu X; Tang L; Yu J; Wang J; Liang T
BMC Bioinformatics; 2023 Jan; 24(1):12. PubMed ID: 36624399
[TBL] [Abstract][Full Text] [Related]
59. Mitotic count reflects prognosis of gallbladder cancer particularly among patients with T3 tumor.
Kai K; Masuda M; Ide T; Takase Y; Miyoshi A; Kitahara K; Miyazaki K; Noshiro H; Tokunaga O
Mol Clin Oncol; 2013 Jul; 1(4):633-638. PubMed ID: 24649220
[TBL] [Abstract][Full Text] [Related]
60. Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma.
Al-Maghrabi J; Al-Ahwal M; Buhmeida A; Syrjänen K; Sibyani A; Emam E; Ghanim A; Al-Qahtani M
J Gastrointest Cancer; 2012 Jun; 43(2):279-87. PubMed ID: 21637966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
